Promise of mGluR2/3 activators in psychiatry

Neuropsychopharmacology. 2009 Jan;34(1):248-9. doi: 10.1038/npp.2008.156.
No abstract available

Publication types

  • Review

MeSH terms

  • Animals
  • Anxiety Disorders / drug therapy
  • Biphenyl Compounds / pharmacology
  • Drug Delivery Systems
  • Humans
  • Indans / pharmacology
  • Mental Disorders / drug therapy*
  • Pyridines / pharmacology
  • Receptors, Metabotropic Glutamate / agonists*
  • Schizophrenia / drug therapy
  • Sulfonamides / pharmacology

Substances

  • Biphenyl Compounds
  • Indans
  • N-(4-(2-methoxyphenoxy)phenyl)-N-(2,2,2-trifluoroethylsulfonyl)pyrid-3-ylmethylamine
  • Pyridines
  • Receptors, Metabotropic Glutamate
  • Sulfonamides
  • biphenyl-indanone A
  • metabotropic glutamate receptor 2
  • metabotropic glutamate receptor 3